Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.
2.

A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. Hospitals.

Puzniak L, DePestel DD, Srinivasan A, Ye G, Murray J, Merchant S, DeRyke CA, Gupta V.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02564-18. doi: 10.1128/AAC.02564-18. Print 2019 Apr.

3.

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study.

McCann E, Srinivasan A, DeRyke CA, Ye G, DePestel DD, Murray J, Gupta V.

Open Forum Infect Dis. 2018 Sep 21;5(10):ofy241. doi: 10.1093/ofid/ofy241. eCollection 2018 Oct.

4.

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.

Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ.

Clin Ther. 2015 Jul 1;37(7):1443-1453.e2. doi: 10.1016/j.clinthera.2015.04.008. Epub 2015 May 15.

PMID:
25982687
5.

Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.

Pettit NN, DePestel DD, Fohl AL, Eyler R, Carver PL.

Pharmacotherapy. 2015 Feb;35(2):119-26. doi: 10.1002/phar.1538.

6.

Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool.

Hermsen ED, McDaneld PM, Eiland EH 3rd, Destache CJ, Lusardi K, Estrada SJ, Mercier RC, DePestel DD, Lamp KC, Anderson E, Chung TJ, McKinnon PS.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S179-84. doi: 10.1093/cid/ciu539.

PMID:
25261545
7.

Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials.

Justo JA, Gauthier TP, Scheetz MH, Chahine EB, Bookstaver PB, Gallagher JC, Hermsen ED, DePestel DD, Ernst EJ, Jacobs DM, Esterly JS, Suda KJ, Olsen KM, Abbo LM, MacDougall C.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S162-9. doi: 10.1093/cid/ciu537.

8.

Assessing appropriateness of antimicrobial therapy: in the eye of the interpreter.

DePestel DD, Eiland EH 3rd, Lusardi K, Destache CJ, Mercier RC, McDaneld PM, Lamp KC, Chung TJ, Hermsen ED.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S154-61. doi: 10.1093/cid/ciu548.

PMID:
25261542
9.

Antimicrobial stewardship: philosophy versus practice.

Dodds Ashley ES, Kaye KS, DePestel DD, Hermsen ED.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S112-21. doi: 10.1093/cid/ciu546.

PMID:
25261538
10.

Outcomes and metrics for antimicrobial stewardship: survey of physicians and pharmacists.

Bumpass JB, McDaneld PM, DePestel DD, Lamp KC, Chung TJ, McKinnon PS, Crompton MG, Hermsen ED.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S108-11. doi: 10.1093/cid/ciu545.

PMID:
25261537
11.

Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.

Eyler RF, Vilay AM, Nader AM, Heung M, Pleva M, Sowinski KM, DePestel DD, Sörgel F, Kinzig M, Mueller BA.

Antimicrob Agents Chemother. 2014;58(3):1320-6. doi: 10.1128/AAC.02090-12. Epub 2013 Dec 9.

12.

Epidemiology of Clostridium difficile infection.

Depestel DD, Aronoff DM.

J Pharm Pract. 2013 Oct;26(5):464-75. doi: 10.1177/0897190013499521. Review.

13.

Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD.

Support Care Cancer. 2012 Sep;20(9):1935-6. doi: 10.1007/s00520-012-1440-9. Epub 2012 Mar 25. No abstract available.

PMID:
22447367
14.

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.

Jorgenson MR, DePestel DD, Carver PL.

Ann Pharmacother. 2011 Nov;45(11):1384-98. doi: 10.1345/aph.1Q225. Epub 2011 Oct 18. Review.

PMID:
22009993
15.

Surgical infection prophylaxis for left ventricular assist device implantation.

Walker PC, DePestel DD, Miles NA, Malani PN.

J Card Surg. 2011 Jul;26(4):440-3. doi: 10.1111/j.1540-8191.2011.01262.x. Epub 2011 May 9.

16.

Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia.

Pogue JM, Alaniz C, Carver PL, Pleva M, Newton D, DePestel DD.

Infect Control Hosp Epidemiol. 2011 Mar;32(3):289-92. doi: 10.1086/658665.

PMID:
21460516
17.

Evaluation of hospital room assignment and acquisition of Clostridium difficile infection.

Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, Chenoweth CE.

Infect Control Hosp Epidemiol. 2011 Mar;32(3):201-6. doi: 10.1086/658669.

PMID:
21460503
18.

Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registry.

DePestel DD, Hershberger E, Lamp KC, Malani PN.

Am J Geriatr Pharmacother. 2010 Dec;8(6):551-61. doi: 10.1016/S1543-5946(10)80004-2.

PMID:
21356504
19.

Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.

Pettit NN, DePestel DD, Malani PN, Riddell J 4th.

HIV Clin Trials. 2010 Nov-Dec;11(6):332-9. doi: 10.1310/hct1106-332.

PMID:
21239361
20.

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD.

Support Care Cancer. 2011 Dec;19(12):1969-74. doi: 10.1007/s00520-010-1038-z. Epub 2010 Nov 26.

PMID:
21110047
21.

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.

Vilay AM, Grio M, Depestel DD, Sowinski KM, Gao L, Heung M, Salama NN, Mueller BA.

Crit Care Med. 2011 Jan;39(1):19-25. doi: 10.1097/CCM.0b013e3181fa36fb. Erratum in: Crit Care Med. 2011 May;39(5):1247.

PMID:
20890189
22.

Managing antimicrobial resistance in intensive care units.

Gandhi TN, DePestel DD, Collins CD, Nagel J, Washer LL.

Crit Care Med. 2010 Aug;38(8 Suppl):S315-23. doi: 10.1097/CCM.0b013e3181e6a2a4. Review.

PMID:
20647789
23.

Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies.

Vilay AM, Shah KH, Churchwell MD, Patel JH, DePestel DD, Mueller BA.

Blood Purif. 2010;30(1):37-43. doi: 10.1159/000316685. Epub 2010 Jun 24.

PMID:
20588011
24.

Drug costs and utilization after implementation of a posaconazole prophylaxis protocol in adults with acute myelogenous leukemia.

Nemerovski CW, Mackler ER, DePestel DD, Collins CD, Welch KS, Stevenson JG.

Am J Health Syst Pharm. 2010 Feb 15;67(4):295-9. doi: 10.2146/ajhp090101.

PMID:
20133535
25.

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.

McCoy D, Depestel DD, Carver PL.

Pharmacotherapy. 2009 Nov;29(11):1306-25. doi: 10.1592/phco.29.11.1306. Review.

PMID:
19857148
26.

Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.

Pogue JM, DePestel DD, Kaul DR, Khaled Y, Frame DG.

Transpl Infect Dis. 2009 Oct;11(5):467-70. doi: 10.1111/j.1399-3062.2009.00426.x. Epub 2009 Jul 22.

27.

Doripenem.

Paterson DL, Depestel DD.

Clin Infect Dis. 2009 Jul 15;49(2):291-8. doi: 10.1086/600036. Review.

PMID:
19527173
28.

Vancomycin use during left ventricular assist device support.

Eyler RF, Butler SO, Walker PC, DePestel DD, Spoor MT, Pagani FD, Malani PN.

Infect Control Hosp Epidemiol. 2009 May;30(5):484-6. doi: 10.1086/597231.

PMID:
19301984
29.

Ertapenem clearance during modeled continuous renal replacement therapy.

Stevenson JM, Patel JH, Churchwell MD, Vilay AM, Depestel DD, Sörgel F, Kinzig M, Jakob V, Mueller BA.

Int J Artif Organs. 2008 Dec;31(12):1027-34.

PMID:
19115194
30.

Cephalosporin use in treatment of patients with penicillin allergies.

DePestel DD, Benninger MS, Danziger L, LaPlante KL, May C, Luskin A, Pichichero M, Hadley JA.

J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):530-40. doi: 10.1331/JAPhA.2008.07006. Review. Erratum in: J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):572.

PMID:
18653431
31.

Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.

Surowiec D, DePestel DD, Carver PL.

Pharmacotherapy. 2008 Jun;28(6):719-29. doi: 10.1592/phco.28.6.719.

32.
33.

Comparison of echinocandin antifungals.

Eschenauer G, Depestel DD, Carver PL.

Ther Clin Risk Manag. 2007 Mar;3(1):71-97.

34.

Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.

Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.

Pharmacotherapy. 2007 Jul;27(7):970-9.

35.

Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.

Collins CD, Stuntebeck ER, DePestel DD, Stevenson JG.

Clin Drug Investig. 2007;27(4):233-41.

PMID:
17358095
36.
37.

Antibiotic allergy.

Eschenauer GA, Regal RE, DePestel DD.

N Engl J Med. 2006 May 25;354(21):2293-4; author reply 2293-4. No abstract available.

PMID:
16723626
38.

Dalbavancin: a new option for the treatment of gram-positive infections.

Lin SW, Carver PL, DePestel DD.

Ann Pharmacother. 2006 Mar;40(3):449-60. Epub 2006 Feb 28. Review.

PMID:
16507624
39.

Are cephalosporins adequate for antimicrobial prophylaxis for cardiac surgery involving implants?

Chenoweth CE, DePestel DD, Prager RL.

Clin Infect Dis. 2005 Jul 1;41(1):122-3; author reply 123-4. No abstract available.

PMID:
15937773
40.

Experience with community-based amphotericin B infusion therapy.

Malani PN, Depestel DD, Riddell J, Bickley S, Klein LR, Kauffman CA.

Pharmacotherapy. 2005 May;25(5):690-7.

41.
42.

Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy.

Prescott WA Jr, DePestel DD, Ellis JJ, Regal RE.

Clin Infect Dis. 2004 Apr 15;38(8):1102-7. Epub 2004 Mar 26.

PMID:
15095214
43.
44.

Linezolid clearance during continuous venovenous hemodiafiltration: a case report.

Kraft MD, Pasko DA, DePestel DD, Ellis JJ, Peloquin CA, Mueller BA.

Pharmacotherapy. 2003 Aug;23(8):1071-5.

45.

Supplemental Content

Loading ...
Support Center